Clinical Trials in Oncology Europe
3 – 4 December, 2024 // Munich, Germany
Join Worldwide Clinical Trials at Clinical Trials in Oncology Europe to network with colleagues, interact with key opinion leaders, and discuss strategies for operational success in clinical trials.
0
days leftAbout event
Topic: Oncology
Many of our oncology team members have dedicated their entire careers to research or clinical care. That means we are familiar with just how complex oncology trials can be – and how to overcome any operational challenges. And our experts are accessible when you need us; we give you and your trial our full attention, every step of the way. If you are attending Clinical Trials in Oncology Europe, stop by booth 18 and say hello.
Matt Cooper, PhD, Executive Director, Therapeutic Strategy Lead, Oncology, will be presenting “Tailored Trial Designs for Precise Outcomes” on 3 December at 2:15 pm CES.
Date
Tuesday to Wednesday
3 – 4 December 2024
Venue
Sofitel Munich Bayerpost
Bayerstraße 12, 80335 München, Germany
Matt Cooper, PhD
Executive Director, Therapeutic Strategy Lead, Oncology
Matt Cooper is the Executive Director, Therapeutic Strategy Lead, Oncology and has 25 years of experience in the life science industry conducting clinical trials across all phases. His experience spans roles at sponsors, sites, and the NHS, and he has extensive experience in site management and expanded use of oncology therapies. He is passionate about building effective relationships between industry stakeholders to drive innovation and patient access.
